TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a report published on Saturday. The firm issued a hold rating on the stock. Separately, Cantor Fitzgerald reaffirmed a neutral rating on shares of TherapeuticsMD in a research note on Thursday, August 17th. View Our Latest Stock Report on TherapeuticsMD TherapeuticsMD Trading Up […]

Leave a Reply

Your email address will not be published.

Previous post EVERTEC (NYSE:EVTC) Downgraded by StockNews.com
Next post Novavax (NASDAQ:NVAX) Upgraded at StockNews.com